Central Pain Syndrome in Survivors of Head and Neck Cancer
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to Head and Neck Cancer
Related studies linked through entity extraction aliases.
High-risk Recurrent or Second Primary HNSCC With PD-1 Antibody Adjuvant After Salvage Surgery(RePASS)
- Status
- UNKNOWN
- Phase
- PHASE2
Long-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular Immunotherapy
- Status
- TERMINATED
- Phase
- N/A
CLR 131 Combined With Radiation for Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Early Access Program Providing HER2/HER3 Bispecific Antibody, MCLA-128, for a Patient With Advanced NRG1-Fusion Positive Solid Tumor
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Photobiomodulation and Sonophoresis Improving Jaw Mobility and Quality of Life Among Head and Neck Cancer Survivors
- Status
- UNKNOWN
- Phase
- NA
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Status
- RECRUITING
- Phase
- N/A
A Phase 1b/2 Study of Serabelisib in Combination With Canagliflozin in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Sentinel Node in Larynx and Pharynx Cancers
- Status
- COMPLETED
- Phase
- NA
Study to Evaluate the Safety of Nanoxel M Inj.
- Status
- UNKNOWN
- Phase
- N/A
Intratumoral Microdosing of TAK-981 in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE2
The SEA CHANGE Study: A Self Management Intervention for Head and Neck Cancer Survivors
- Status
- UNKNOWN
- Phase
- NA
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity of AAV2hAQP1 in Subjects With Radiation-Induced Parotid Gland Hypofunction and Xerostomia
- Status
- COMPLETED
- Phase
- PHASE1
Microvascular Function in Patients Undergoing 5-Fluorouracil Chemotherapy
- Status
- COMPLETED
- Phase
- N/A
Postoperative Changes in Head and Neck Cancer Patients Undergoing Surgery
- Status
- COMPLETED
- Phase
- N/A
Osteoradionecrosis Rate in Patients Undergoing Radiotherapy for Head and Neck Cancer Treatment.
- Status
- UNKNOWN
- Phase
- N/A
Salivary Gland Autotransplantation for Treatment of XRT Induced Xerostomia
- Status
- COMPLETED
- Phase
- NA
Comparison of Choosing Free ALT or Free PMT for Reconstruction With Head and Neck Cancer
- Status
- COMPLETED
- Phase
- N/A